Phase 3 Trial Confirms Sarilumab Improves Polymyalgia Rheumatica Outcomes
Vibeke Strand, MD Credit: PRIME Education New phase 3 data supported the effectiveness of sarilumab 200 mg every…
Patient dies in Sarepta gene therapy trial, adding to safety concerns
A 51-year-old man died last month after receiving an experimental gene therapy developed by Sarepta Therapeutics for an…